Companies / Hanover Insurance Group, Inc. / Activity
Activity — Hanover Insurance Group, Inc.
68 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Roche John C CEO | Other | Common Stock | $2.57M | -14K -9.17% | 140,858 0.40% of shares | low |
| Feb 5, 2026 | Lavey Richard W Executive | Sell | Common Stock | $1.61M | -9K -18.60% | 39,174 0.11% of shares | medium |
| Feb 5, 2026 | Lavey Richard W Executive | Exercise | Common Stock | $1.36M | +17K +44.47% | 56,594 0.16% of shares | low |
| Feb 27, 2026 | Farber Jeffrey M Executive | Other | Common Stock | $994.7K | -6K -9.62% | 51,716 0.15% of shares | low |
| Feb 5, 2026 | Lavey Richard W Executive | Sell | Common Stock | $772.6K | -4K -7.67% | 52,255 0.15% of shares | medium |
| Feb 5, 2026 | Lavey Richard W Executive | Sell | Common Stock | $737.8K | -4K -7.90% | 48,128 0.14% of shares | medium |
| Feb 5, 2026 | Lavey Richard W Executive | Sell | Common Stock | $732.1K | -4K -10.49% | 35,063 0.10% of shares | medium |
| Feb 27, 2026 | Lavey Richard W Executive | Other | Common Stock | $581.6K | -3K -8.56% | 34,383 0.10% of shares | low |
| Feb 27, 2026 | Salvatore Bryan J Executive | Other | Common Stock | $507.0K | -3K -8.81% | 29,039 0.08% of shares | low |
| Feb 5, 2026 | Lavey Richard W Executive | Sell | Common Stock | $466.5K | -3K -7.45% | 32,452 0.09% of shares | medium |
| Feb 27, 2026 | Kerrigan Dennis Francis Executive | Other | Common Stock | $316.3K | -2K -12.76% | 11,969 0.03% of shares | low |
| Feb 27, 2026 | Lee Willard T Executive | Other | Common Stock | $219.5K | -1K -14.85% | 6,969 0.02% of shares | low |
| Feb 27, 2026 | Lowsley Denise Executive | Other | Common Stock | $218.0K | -1K -19.66% | 4,932 0.01% of shares | low |
| Feb 27, 2026 | Carlin Jane D Director | Sell | Common Stock | $217.1K | -1K -33.12% | 2,423 <0.01% of shares | medium |
| Feb 27, 2026 | Lovely David John Executive | Other | Common Stock | $192.9K | -1K -21.96% | 3,795 0.01% of shares | low |
| Feb 5, 2026 | Lavey Richard W Executive | Sell | Common Stock | $50.0K | -278 -0.86% | 32,174 0.09% of shares | low |
| Jun 26, 2026 | Bunting Theodore H JR Director | Grant | Common Stock | $0 | +4 +0.05% | 7,035 0.02% of shares | low |
| May 12, 2026 | Bunting Theodore H JR Director | Grant | Common Stock | $0 | +843 +13.62% | 7,031 0.02% of shares | low |
| Jun 26, 2026 | Lavey Richard W Executive | Grant | Common Stock | $0 | +28 +0.08% | 34,447 0.10% of shares | low |
| Jun 26, 2026 | Farber Jeffrey M Executive | Grant | Common Stock | $0 | +43 +0.08% | 51,812 0.15% of shares | low |
| Jun 26, 2026 | Lane Kathy S Director | Grant | Common Stock | $0 | +4 +0.14% | 2,773 <0.01% of shares | low |
| May 12, 2026 | Lane Kathy S Director | Grant | Common Stock | $0 | +843 +43.77% | 2,769 <0.01% of shares | low |
| Jun 26, 2026 | Ramrath Joseph R Director | Grant | Common Stock | $0 | +4 +0.01% | 33,834 0.10% of shares | low |
| May 12, 2026 | Ramrath Joseph R Director | Grant | Common Stock | $0 | +843 +2.56% | 33,830 0.10% of shares | low |
| Mar 27, 2026 | Lovely David John Executive | Grant | Common Stock | $0 | +13 +0.35% | 3,808 0.01% of shares | low |
| Feb 24, 2026 | Lovely David John Executive | Grant | Common Stock | $0 | +793 +19.49% | 4,862 0.01% of shares | low |
| Feb 24, 2026 | Lovely David John Executive | Grant | Common Stock | $0 | +698 +20.70% | 4,069 0.01% of shares | low |
| Feb 24, 2026 | Lovely David John Executive | Grant | Common Stock | $0 | +1K +47.26% | 3,371 <0.01% of shares | low |
| Mar 27, 2026 | Lee Willard T Executive | Grant | Common Stock | $0 | +14 +0.19% | 6,982 0.02% of shares | low |
| Feb 24, 2026 | Lee Willard T Executive | Grant | Common Stock | $0 | +793 +10.73% | 8,183 0.02% of shares | low |
| Feb 24, 2026 | Lee Willard T Executive | Grant | Common Stock | $0 | +744 +11.19% | 7,390 0.02% of shares | low |
| Feb 24, 2026 | Lee Willard T Executive | Grant | Common Stock | $0 | +1K +21.01% | 6,646 0.02% of shares | low |
| Mar 27, 2026 | Kerrigan Dennis Francis Executive | Grant | Common Stock | $0 | +19 +0.16% | 11,988 0.03% of shares | low |
| Feb 24, 2026 | Kerrigan Dennis Francis Executive | Grant | Common Stock | $0 | +1K +8.86% | 13,720 0.04% of shares | low |
| Feb 24, 2026 | Kerrigan Dennis Francis Executive | Grant | Common Stock | $0 | +1K +9.71% | 12,603 0.04% of shares | low |
| Feb 24, 2026 | Kerrigan Dennis Francis Executive | Grant | Common Stock | $0 | +2K +17.73% | 11,488 0.03% of shares | low |
| Mar 27, 2026 | Salvatore Bryan J Executive | Grant | Common Stock | $0 | +31 +0.11% | 29,069 0.08% of shares | low |
| Feb 24, 2026 | Salvatore Bryan J Executive | Grant | Common Stock | $0 | +2K +6.25% | 31,845 0.09% of shares | low |
| Feb 24, 2026 | Salvatore Bryan J Executive | Grant | Common Stock | $0 | +2K +5.91% | 29,972 0.09% of shares | low |
| Feb 24, 2026 | Salvatore Bryan J Executive | Grant | Common Stock | $0 | +3K +10.10% | 28,300 0.08% of shares | low |
| Mar 27, 2026 | Lowsley Denise Executive | Grant | Common Stock | $0 | +12 +0.25% | 4,945 0.01% of shares | low |
| Feb 24, 2026 | Lowsley Denise Executive | Grant | Common Stock | $0 | +649 +11.82% | 6,138 0.02% of shares | low |
| Feb 24, 2026 | Lowsley Denise Executive | Grant | Common Stock | $0 | +744 +15.68% | 5,489 0.02% of shares | low |
| Feb 24, 2026 | Lowsley Denise Executive | Grant | Common Stock | $0 | +1K +32.13% | 4,745 0.01% of shares | low |
| Jan 23, 2026 | Carlin Jane D Director | Other | Common Stock | $0 | +4K | 3,623 0.01% of shares | low |
| Jan 23, 2026 | Carlin Jane D Director | Other | Common Stock | $0 | -4K -61.11% | 2,306 <0.01% of shares | low |
| Mar 27, 2026 | Roche John C CEO | Grant | Common Stock | $0 | +153 +0.11% | 141,011 0.40% of shares | low |
| Feb 24, 2026 | Roche John C CEO | Grant | Common Stock | $0 | +9K +6.48% | 155,078 0.45% of shares | low |
| Feb 24, 2026 | Roche John C CEO | Grant | Common Stock | $0 | +9K +6.23% | 145,643 0.42% of shares | low |
| Feb 24, 2026 | Roche John C CEO | Grant | Common Stock | $0 | +13K +10.70% | 137,103 0.39% of shares | low |